Co‐staining with the LAM marker α‐smooth muscle actin (αSMA) revealed co‐localization with both MAO‐A and MAO‐B positivity in LAM lesions, with MAO‐B being confined to pathological areas (Fig 3B). The gene discussed is TSC2; the disease is lymphangioleiomyomatosis.